4//SEC Filing
FISCHER JOST 4
Accession 0001610717-25-000124
CIK 0001837607other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:50 PM ET
Size
6.8 KB
Accession
0001610717-25-000124
Insider Transaction Report
Form 4
FISCHER JOST
Director
Transactions
- Purchase
Class A Common Stock
2025-05-19$0.50/sh+50,000$24,940→ 146,785 total - Purchase
Class A Common Stock
2025-05-20$0.51/sh+60,000$30,360→ 206,785 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades in prices ranging from $0.4844 to $0.51, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- [F2]This transaction was executed in multiple trades in prices ranging from $0.50 to $0.5132, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
Documents
Issuer
AEON Biopharma, Inc.
CIK 0001837607
Entity typeother
Related Parties
1- filerCIK 0001366841
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:50 PM ET
- Size
- 6.8 KB